Draganfly Inc.
DPRO Nasdaq Aircraft Financials FY2019โFY2025
What Draganfly Inc. does
No business description yet.
- Legal name
- Draganfly Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 40-F ยท Mar 24, 2026
- Accession ยท CIK
- 0001493152-26-012377
0001786286
Revenue and margins
Draganfly Inc. had $5.5M of revenue in fiscal 2025, up 15.4% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was โ$17.7M in fiscal 2025, โ320.8% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Draganfly Inc. returned โ to shareholders in fiscal 2025. The diluted share count rose 397.8%.
Balance sheet
Cash, debt and the ratios that show how comfortably Draganfly Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $18.2M | $5.8M | $2.3M | $4.3M | $65.8M |
| Current ratio | 5.0x | 4.0x | 0.9x | 1.7x | 21.6x |
| Quick ratio | 4.5x | 3.7x | 0.7x | 1.4x | 20.8x |
| Total assets | $33.1M | $10.8M | $6.3M | $7.1M | $74.0M |
| Total liabilities | $5.7M | $2.7M | $6.0M | $3.9M | $3.5M |
| Shareholders' equity | $27.5M | $8.2M | $0.3M | $3.2M | $70.6M |
| Net debt (โ = net cash) | โ | โ | โ | โ | โ |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. โPlanโ marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
โ
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8โ9 is strong, 0โ2 weak.
| Test | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Net income is positive | โ | โ | โ | โ | โ | โ | โ |
| Cash from operations is positive | โ | โ | โ | โ | โ | โ | โ |
| Return on assets rose | โ | โ | โ | โ | โ | โ | โ |
| Cash from operations exceeds net income | โ | โ | โ | โ | โ | โ | โ |
| Debt fell relative to assets | โ | โ | โ | โ | โ | โ | โ |
| Current ratio rose | โ | โ | โ | โ | โ | โ | โ |
| Share count didn't rise | โ | โ | โ | โ | โ | โ | โ |
| Gross margin rose | โ | โ | โ | โ | โ | โ | โ |
| Revenue rose relative to assets | โ | โ | โ | โ | โ | โ | โ |
| F-score | โ / 1 | โ / 3 | 2 / 8 | 3 / 8 | 3 / 8 | 3 / 8 | 2 / 8 |
| Accruals ratio | โ | โ | 23.9% | โ39.5% | โ41.9% | โ22.3% | 1.6% |
| Altman Z'' | โ | โ | โ | โ | โ | โ | โ |
7 years of figures
Amounts in USD. Hover a ratioโs name for its definition.
| Fiscal year | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | $1.0M | $3.3M | $5.6M | $5.8M | $4.9M | $4.8M | $5.5M |
| Gross profit | $0.9M | $1.3M | $2.1M | $0.6M | $1.5M | $1.0M | $0.9M |
| Research and development | $0.0M | $0.4M | $0.4M | $0.5M | $1.2M | $0.7M | $0.7M |
| Net income | โ$8.4M | โ$6.0M | โ$12.9M | โ$21.2M | โ$17.5M | โ$10.1M | โ$16.4M |
| Diluted EPS | โ | โ | $0.47 | โ$15.62 | โ$10.80 | โ$3.21 | โ$1.04 |
| Diluted shares | 0.01B | 0.02B | 0.03B | 0.00B | 0.00B | 0.00B | 0.02B |
| Cash flow | |||||||
| Cash from operations | โ | โ | โ$17.6M | โ$12.6M | โ$13.9M | โ$8.6M | โ$17.1M |
| Capital expenditure | $0.1M | $0.0M | $0.2M | $0.1M | $0.4M | $0.1M | $0.7M |
| Free cash flow | โ | โ | โ$17.7M | โ$12.6M | โ$14.3M | โ$8.8M | โ$17.7M |
| Stock-based compensation | $0.6M | $2.0M | $3.2M | $2.5M | $1.5M | $0.9M | $1.0M |
| Balance sheet | |||||||
| Cash and short-term investments | $1.9M | $1.6M | $18.2M | $5.8M | $2.3M | $4.3M | $65.8M |
| Current assets | โ | $3.4M | $26.4M | $10.0M | $5.0M | $6.3M | $72.9M |
| Current liabilities | โ | $2.5M | $5.3M | $2.5M | $5.6M | $3.6M | $3.4M |
| Inventory | $0.0M | $1.0M | $2.7M | $0.8M | $1.2M | $1.1M | $2.9M |
| Property and equipment, net | โ | $0.1M | $0.2M | $0.3M | $0.5M | $0.4M | $0.9M |
| Goodwill | โ | $1.7M | $4.7M | โ | โ | โ | โ |
| Intangible assets | โ | $0.2M | $0.5M | $0.1M | $0.0M | $0.0M | $0.0M |
| Total assets | โ | $5.6M | $33.1M | $10.8M | $6.3M | $7.1M | $74.0M |
| Total liabilities | โ | $2.6M | $5.7M | $2.7M | $6.0M | $3.9M | $3.5M |
| Shareholders' equity | $1.7M | $3.0M | $27.5M | $8.2M | $0.3M | $3.2M | $70.6M |
| Margins | |||||||
| Gross margin | 84.1% | 40.3% | 37.5% | 10.4% | 31.5% | 21.3% | 17.1% |
| Net margin | โ803.7% | โ183.7% | โ229.7% | โ363.6% | โ360.2% | โ211.5% | โ297.3% |
| FCF margin | โ | โ | โ315.0% | โ216.0% | โ293.9% | โ182.9% | โ320.8% |
| Returns | |||||||
| Return on equity | โ495.8% | โ253.9% | โ84.7% | โ119.2% | โ413.4% | โ575.6% | โ44.6% |
| Return on assets | โ | โ107.2% | โ66.8% | โ96.7% | โ204.6% | โ151.5% | โ40.5% |
| Return on tangible equity | โ495.8% | โ540.8% | โ57.9% | โ264.8% | โ6,599.1% | โ318.5% | โ23.3% |
| Growth | |||||||
| Revenue growth | โ | 212.8% | 73.0% | 3.8% | โ16.9% | โ1.4% | 15.4% |
| EPS growth | โ | โ | โ | โ3,419.3% | โ | โ | โ |
| Share count change | โ | 73.8% | 67.8% | โ95.2% | 20.6% | 95.0% | 397.8% |
| Financial health | |||||||
| Current ratio | โ | 1.4x | 5.0x | 4.0x | 0.9x | 1.7x | 21.6x |
| Quick ratio | โ | 1.0x | 4.5x | 3.7x | 0.7x | 1.4x | 20.8x |
| Capital allocation | |||||||
| Capex / revenue | 6.4% | 0.5% | 3.0% | 1.0% | 7.5% | 2.5% | 11.9% |
| Stock comp / revenue | 55.2% | 61.2% | 56.0% | 43.5% | 30.8% | 18.0% | 18.0% |
| Quality scores | |||||||
| Piotroski F-score | โ | โ | 2.0 | 3.0 | 3.0 | 3.0 | 2.0 |
| Accruals ratio | โ | โ | 23.9% | โ39.5% | โ41.9% | โ22.3% | 1.6% |
Source: SEC EDGAR XBRL filings (CIK 0001786286). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. Filed in CAD under IFRS and converted to US$: income and cash-flow lines at each period's average exchange rate, balance-sheet lines at the period-end rate. For information only โ not investment advice. Check the original filings before relying on any figure.
